Regulaxis is a biotechnology company that is engaged in the research, development, and licensing of synthetic molecules for use in human treatments. It provides therapies based on synthetic peptides regulating cell growth and differentiation. The company focuses on a range of therapeutic areas covering nerve cell regeneration, cancer, and metabolic diseases.